Govt Approves Sinovac Jabs 'in The Public Interest'
"); jQuery("#212 h3").html("
"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1576185_1_20210218193250.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1576185-20210218.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1576185-20210218.htm', 'DCS.dcsqry', '' ); } } }); }); });
2021-02-18 HKT 12:16
Share this story
The government on Thursday approved the use of a Covid-19 vaccine made by mainland firm Sinovac, describing it as a necessary move and one that is in the public interest.
Experts advising the SAR authorities on coronavirus vaccines said earlier this week that with a reported efficacy rate of 62.3 percent, the protection offered by the Sinovac jabs would outweigh any risks.
A million doses of the vaccine are expected to arrive in Hong Kong on Friday, with doctors anticipating that the vaccination programme could be rolled out as soon as next week.
A government statement said the secretary for health considered it necessary to approve the Sinovac jabs after considering the experts' opinion and the public health risks posed by the pandemic.
The statement said the government will complete the necessary quality checks after receiving the jabs, and will continue to ask Sinovac to provide it with the latest clinical data.
The SAR government eventually decided not to require the mainland company to publish clinical data in medical journals before its jabs could be approved here. The vaccine has so far not been approved by the World Health Organisation.
The Sinovac vaccine is the second approved for use in the SAR, after jabs made by German firm BioNTech were earlier given the green light.
SBI Holdings To Acquire Bitbank In US$289M Crypto Expansion
SBI Holdings has agreed to acquire Japanese crypto exchange Bitbank in a deal valued at approximately US$289 million, w... Read more
4 Ways Hong Kong Banks Fight Financial Crime Using AI, According To HKMA
The Hong Kong Monetary Authority (HKMA) wants banks to use AI in financial crime as a way to counter cyberattacks and s... Read more
Ripple Launches RLUSD Stablecoin In Japan Through SBI Group
Ripple has launched its US dollar-denominated stablecoin, Ripple USD, in the Japanese market. The expansion follows reg... Read more
SBI And Startale Launch Trust Bank-Backed Yen Stablecoin JPYSC In Japan
SBI Group has introduced its trust based stablecoin JPYSC in partnership with Singapore-based fintech company Startale ... Read more
Visa Study: Digital Wallets Lead Greater Bay Area Payment Preferences
Visa has released its latest Consumer Payment Attitudes Study, highlighting how payment seamlessness is linked to a shi... Read more
European And South Korean Banks Form Project Pangea For FX Settlement
Chainlink, South Korean infrastructure provider FairSquareLab, the Unified Korea Alliance (UniKA), and European stablec... Read more